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ly reported, though only in a retrospective manner or in prospective
single-Institute studies (Ordonez et al., 2014; Ozsahin et al., 2005;
Azria et al., 2008; Bordon et al., 2010; Foro et al., 2014) an inverse rela-
tionship between the percentage of apoptosis in irradiated lymphocytes
and late toxicity emerged also in this report (Azria et al., 2015). Themech-
anism of this inverse association is not completely clear, being possibly
related to the delay of cells in recognizing the radiation-induced cell dam-Late radiation-induced side effects are a major concern for both cli-
observed by Azria et al. for increasing values of RILA, while no Grade 3
breast ﬁbrosiswas observed in patients with RILA N12%, with a negativenicians and patients, owing to their frequent irreversibility and possibly
permanent detrimental effect on quality of life. Despite technological
reﬁnements simply unimaginable less than 10–15 years ago, a signiﬁ-
cant fraction of patients still experience severe long-term sequelae
after radiotherapy. It is surprising to observe how in some cohorts of
subjects treated on the same anatomical site, with identical radiation
doses and techniques and with comparable doses unavoidably deliv-
ered to healthy tissues surrounding the tumor, only a minority of
subjects occasionally develop dramatic late sequelae, while all the
others pass through irradiation with no, or only minimal, negative
consequences. Such a phenomenon is explainable only by hypothesiz-
ing the existence of individual radiosensitivity.
In their elegant paper in this issue of EBioMedicine, Azria et al. report
on the ﬁrst prospective, multi-Institute trial investigating the role of
Radiation Induced Lymphocyte Apoptosis (RILA) as a predictor of breast
ﬁbrosis after adjuvant radiotherapy following breast conservative
surgery (Azria et al., 2015).
RILA, deﬁned as the percentage of peripheral blood lymphocyte
(PBL) death induced by a certain radiation doseminus the spontaneous
cell death (Ordonez et al., 2014), is a versatile, rapid and reproducible
assay of radiosensitivity on PBL (Crompton and Ozsahin, 1997;
Ozsahin et al., 2005). In general, radiobiological normal tissue assays
are technically more convenient and feasible than tumor tissue assays
(Azria et al., 2012). Lymphocytes, in particular, appear to be the ideal
candidates for such analyses, owing to both their accessibility andm.2015.10.024.
. This is an open access article underage and initiating apoptosis, with a consequently increased risk of toxicity
and, theoretically, of cancer radioresistance and reduced tumor control.
In particular, a decreased incidence of Grade ≥ 2 breast ﬁbrosis was
predictive value of 91% for RILA ≥20%. The positive predictive valuewas,
on the contrary, much lower (22% for RILA ≤12%) (Azria et al., 2015).
This ﬁnding, far from weakening or reducing the translational signiﬁ-
cance of this trial, simply suggests that, as appropriately highlighted
by the Authors (Azria et al., 2015), a biological assay is not, in itself,
sufﬁcient to predict the risk of late effects. In the French multicentric
study, treatment-related and behavioural factors (namely, adjuvant
hormonal therapy and tobacco smoking) also emerged as strong predic-
tors of complication-relapse-free-survival (CRFS) (Azria et al., 2015).
On the contrary, and as previously described (Ozsahin et al., 2005),
no correlation emerged between RILA and acute toxicity, leading the
Authors to postulate that mechanisms other than DNA repair are repre-
sented by the RILA assay (Azria et al., 2015).
No predictive value emerged for RILAwith respect to oncological out-
come. This is not surprising, given the overall favorable prognosis of the
analyzed cohort, in which clinical relapses and deaths occurred in only
2.6% and 1.1%, respectively, of the cases. As emphasized in the paper,
breast cancer is of course not the most appropriate cancer in which to
evaluate the possible prognostic signiﬁcance of RILA, which has been
demonstrated, on the contrary, in more aggressive neoplasms such as
cervical (Ordonez et al., 2014) and prostate carcinoma (Foro et al.,
2014), thoughnot conﬁrmed in a prospective Swiss study on 399 patients
with miscellaneous cancers (Ozsahin et al., 2005). Undoubtedly, the
possible association between the radiosensitivity of normal tissues and
clinical outcome deserves further thorough investigation (Ordonez
et al., 2014).
The Authors are to be commended for their efforts to thoroughly in-
vestigate the possible existence of an intrinsic individual radiosensitivi-
ty which may ultimately predict an enhanced and aberrant individualthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1853C. Cozzarini / EBioMedicine 2 (2015) 1852–1853susceptibility to radiation injury. More in general, the moment ap-
pears to be fast approaching when both RILA and/or well deﬁned
networks of Single Nucleotide Polymorphisms (SNPs), other promis-
ing though less reproducible and of more complex interpretation
markers of both radiosensistivity and radioresistance (Azria et al.,
2008; Reuther et al., 2015), will allow the selection of patients with
a reasonably low risk of late radiation-induced sequelae, given
their promising negative predictive value. This achievement would
be of enormous clinical importance, especially for those tumors
(e.g. prostate cancer) for which radiotherapy represents a valid alterna-
tive to surgery. Once similarly excellent clinical outcomes achievable
with both treatment modalities are ascertained, the preferences of
prostate cancer patients are in fact strongly impacted by the fear of
side-effects (Avila et al., 2015).
The availability of quick, easy and reproducible tools able to improve
the prediction of the excessive or reduced risk of a given subject's devel-
opingwell-deﬁned late sequelaewould be of inestimable value for both
patients and clinicians, especially for tumors such as lung, prostate, head
and neck cancers and sarcomas, for which dose-escalation has a well-
documented role.
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